Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Everolimus 1.5 mg	282
Overall Study	STARTED	Everolimus 3.0 mg	168
Overall Study	STARTED	Mycophenolate Mofetil	271
Overall Study	Completed 12 Month	Everolimus 1.5 mg	250
Overall Study	Completed 12 Month	Everolimus 3.0 mg	149
Overall Study	Completed 12 Month	Mycophenolate Mofetil	248
Overall Study	COMPLETED	Everolimus 1.5 mg	236
Overall Study	COMPLETED	Everolimus 3.0 mg	141
Overall Study	COMPLETED	Mycophenolate Mofetil	226
Overall Study	NOT COMPLETED	Everolimus 1.5 mg	46
Overall Study	NOT COMPLETED	Everolimus 3.0 mg	27
Overall Study	NOT COMPLETED	Mycophenolate Mofetil	45

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00300274/flow